162 related articles for article (PubMed ID: 19455022)
1. Effect of combined treatment methods on quality of life in patients with pancreatic cancer.
Heras P; Kritikos K; Hatzopoulos A; Kritikos N; Karagiannis S; Mitsibounas D
Am J Ther; 2009; 16(4):316-8. PubMed ID: 19455022
[TBL] [Abstract][Full Text] [Related]
2. [Effect of combined treatment methods on quality of life in patients with pancreatic cancer].
Brasiūniene B; Brasiūnas V; Juozaityte E
Medicina (Kaunas); 2006; 42(10):817-22. PubMed ID: 17090981
[TBL] [Abstract][Full Text] [Related]
3. Impact of gemcitabine chemotherapy and 3-dimensional conformal radiation therapy/5-fluorouracil on quality of life of patients managed for pancreatic cancer.
Short M; Goldstein D; Halkett G; Reece W; Borg M; Zissiadis Y; Kneebone A; Spry N
Int J Radiat Oncol Biol Phys; 2013 Jan; 85(1):157-62. PubMed ID: 22543205
[TBL] [Abstract][Full Text] [Related]
4. The effect of combined treatment methods on survival and toxicity in patients with pancreatic cancer.
Brasiūniene B; Juozaityte E
Medicina (Kaunas); 2007; 43(9):716-25. PubMed ID: 17986845
[TBL] [Abstract][Full Text] [Related]
5. Impact of FOLFIRINOX compared with gemcitabine on quality of life in patients with metastatic pancreatic cancer: results from the PRODIGE 4/ACCORD 11 randomized trial.
Gourgou-Bourgade S; Bascoul-Mollevi C; Desseigne F; Ychou M; Bouché O; Guimbaud R; Bécouarn Y; Adenis A; Raoul JL; Boige V; Bérille J; Conroy T
J Clin Oncol; 2013 Jan; 31(1):23-9. PubMed ID: 23213101
[TBL] [Abstract][Full Text] [Related]
6. Patient-reported outcomes of a multicenter phase 2 study investigating gemcitabine and stereotactic body radiation therapy in locally advanced pancreatic cancer.
Rao AD; Sugar EA; Chang DT; Goodman KA; Hacker-Prietz A; Rosati LM; Columbo L; O'Reilly E; Fisher GA; Zheng L; Pai JS; Griffith ME; Laheru DA; Iacobuzio-Donahue CA; Wolfgang CL; Koong A; Herman JM
Pract Radiat Oncol; 2016; 6(6):417-424. PubMed ID: 27552809
[TBL] [Abstract][Full Text] [Related]
7. [Pancreatic cancer--diagnostics and therapy].
Schramm H
Zentralbl Chir; 2003 May; 128(5):367. PubMed ID: 12813632
[No Abstract] [Full Text] [Related]
8. [Locally advanced unresectable pancreatic cancer: Induction chemoradiotherapy followed by maintenance gemcitabine versus gemcitabine alone: Definitive results of the 2000-2001 FFCD/SFRO phase III trial].
Barhoumi M; Mornex F; Bonnetain F; Rougier P; Mariette C; Bouché O; Bosset JF; Aparicio T; Mineur L; Azzedine A; Hammel P; Butel J; Stremsdoerfer N; Maingon P; Bedenne L; Chauffert B
Cancer Radiother; 2011 Jun; 15(3):182-91. PubMed ID: 21315644
[TBL] [Abstract][Full Text] [Related]
9. Survival outcomes in patients with early stage, resected pancreatic cancer - a comparison of gemcitabine- and 5-fluorouracil-based chemotherapy and chemoradiation regimens.
Kizilbash SH; Ward KC; Liang JJ; Jaiyesimi I; Lipscomb J
Int J Clin Pract; 2014 May; 68(5):578-89. PubMed ID: 24472057
[TBL] [Abstract][Full Text] [Related]
10. [Chemoradiation for pancreatic adenocarcinoma].
Flandin I; Mornex F; Claude L; Kubas A; Khodri M; Wautot V; Mazeron R; Partensky C
Cancer Radiother; 2004 Nov; 8 Suppl 1():S80-7. PubMed ID: 15679252
[TBL] [Abstract][Full Text] [Related]
11. Gemcitabine following radiotherapy with concurrent 5-fluorouracil for nonmetastatic adenocarcinoma of the pancreas.
Kachnic LA; Shaw JE; Manning MA; Lauve AD; Neifeld JP
Int J Cancer; 2001 Apr; 96(2):132-9. PubMed ID: 11291097
[TBL] [Abstract][Full Text] [Related]
12. In response to Li et al.: Concurrent chemoradiotherapy treatment of locally advanced pancreatic cancer: gemcitabine versus 5-fluorouracil, a randomized controlled study. IJROBP 2003;57:98-104.
Crane CH
Int J Radiat Oncol Biol Phys; 2004 Mar; 58(3):1009; author reply 1009-10. PubMed ID: 14967465
[No Abstract] [Full Text] [Related]
13. Fluorouracil vs gemcitabine chemotherapy before and after fluorouracil-based chemoradiation following resection of pancreatic adenocarcinoma: a randomized controlled trial.
Regine WF; Winter KA; Abrams RA; Safran H; Hoffman JP; Konski A; Benson AB; Macdonald JS; Kudrimoti MR; Fromm ML; Haddock MG; Schaefer P; Willett CG; Rich TA
JAMA; 2008 Mar; 299(9):1019-26. PubMed ID: 18319412
[TBL] [Abstract][Full Text] [Related]
14. [Chemotherapy and radiotherapy for inoperable pancreatic cancer. A survey of a Cochrane review].
Bjerregaard JK; Pfeiffer P
Ugeskr Laeger; 2007 Nov; 169(46):3949-52. PubMed ID: 18078646
[No Abstract] [Full Text] [Related]
15. Evaluation of clinical factors and treatment results in patients with advanced pancreatic cancer.
Brasiūnas V; Brasiūniene B; Juozaityte E; Barauskas G
Medicina (Kaunas); 2004; 40(11):1074-80. PubMed ID: 15547308
[TBL] [Abstract][Full Text] [Related]
16. Hypofractionated Conformal Radiotherapy with Concurrent Full-Dose Gemcitabine Versus Standard Fractionation Radiotherapy with Concurrent Fluorouracil for Unresectable Pancreatic Cancer: a Multi-Institution Experience.
Rakhra S; Strauss JB; Robertson J; McGinn CJ; Kim T; Huang J; Blake A; Helenowski I; Hayes JP; Mulcahy M; Small W
J Gastrointest Cancer; 2016 Jun; 47(2):196-201. PubMed ID: 27112332
[TBL] [Abstract][Full Text] [Related]
17. Impact of different treatment methods on survival in advanced pancreatic cancer.
Brasiūniene B; Juozaityte E; Barauskas G
Medicina (Kaunas); 2005; 41(5):382-5. PubMed ID: 15947521
[TBL] [Abstract][Full Text] [Related]
18. Maintenance chemotherapy after chemoradiation improves survival of patients with locally advanced pancreatic carcinoma: a retrospective analysis of prospectively recruited patients.
Brunner TB; Tinkl D; Grabenbauer GG; Meyer T; Brueckl WM; Sauer R
Strahlenther Onkol; 2006 Apr; 182(4):210-5. PubMed ID: 16622622
[TBL] [Abstract][Full Text] [Related]
19. Clinical update of gemcitabine in pancreas cancer.
Au E
Gan To Kagaku Ryoho; 2000 May; 27 Suppl 2():469-73. PubMed ID: 10895197
[TBL] [Abstract][Full Text] [Related]
20. Quality of life in a prospective, multicenter phase 2 trial of neoadjuvant full-dose gemcitabine, oxaliplatin, and radiation in patients with resectable or borderline resectable pancreatic adenocarcinoma.
Serrano PE; Herman JM; Griffith KA; Zalupski MM; Kim EJ; Bekaii-Saab TS; Ben-Josef E; Dawson LA; Ringash J; Wei AC
Int J Radiat Oncol Biol Phys; 2014 Oct; 90(2):270-7. PubMed ID: 25104069
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
